Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies
Obesity and cancer cachexia are diseases at opposite ends of the BMI. However, despite the apparent dichotomy, these pathologies share some common underlying mechanisms that lead to profound metabolic perturbations. Insulin resistance, adipose tissue lipolysis, skeletal muscle atrophy and systemic i...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 August 2020
|
| In: |
Current opinion in pharmacology
Year: 2020, Jahrgang: 53, Pages: 101-116 |
| ISSN: | 1471-4973 |
| DOI: | 10.1016/j.coph.2020.07.006 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.coph.2020.07.006 Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S1471489220300448 |
| Verfasserangaben: | Claudia-Eveline Molocea, Foivos-Filippos Tsokanos and Stephan Herzig |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1744940991 | ||
| 003 | DE-627 | ||
| 005 | 20230426074220.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210119s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.coph.2020.07.006 |2 doi | |
| 035 | |a (DE-627)1744940991 | ||
| 035 | |a (DE-599)KXP1744940991 | ||
| 035 | |a (OCoLC)1341388937 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Molocea, Claudia-Eveline |e VerfasserIn |0 (DE-588)122535904X |0 (DE-627)1744942129 |4 aut | |
| 245 | 1 | 0 | |a Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies |c Claudia-Eveline Molocea, Foivos-Filippos Tsokanos and Stephan Herzig |
| 264 | 1 | |c 29 August 2020 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.01.2021 | ||
| 520 | |a Obesity and cancer cachexia are diseases at opposite ends of the BMI. However, despite the apparent dichotomy, these pathologies share some common underlying mechanisms that lead to profound metabolic perturbations. Insulin resistance, adipose tissue lipolysis, skeletal muscle atrophy and systemic inflammation are key players in both diseases. Several strategies for pharmacological treatments have been employed in obesity and cancer cachexia but demonstrated only limited effects. Therefore, there is still a need to develop novel, more effective strategies. In this review we summarize existing therapies and discuss potential novel strategies that could arise by bridging common aspects between obesity and cachexia. We discuss the potential role of macrophage manipulation and the modulation of inflammation by targeting Nuclear Receptors (NRs) as potential novel therapeutic strategies. | ||
| 700 | 1 | |a Tsokanos, Foivos Filippos |e VerfasserIn |0 (DE-588)1078365881 |0 (DE-627)838431739 |0 (DE-576)450767280 |4 aut | |
| 700 | 1 | |a Herzig, Stephan |d 1969- |e VerfasserIn |0 (DE-588)12146623X |0 (DE-627)705470857 |0 (DE-576)292725949 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current opinion in pharmacology |d Amsterdam [u.a.] : Elsevier Science, 2001 |g 53(2020), Seite 101-116 |h Online-Ressource |w (DE-627)325615276 |w (DE-600)2038524-9 |w (DE-576)267762003 |x 1471-4973 |7 nnas |a Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies |
| 773 | 1 | 8 | |g volume:53 |g year:2020 |g pages:101-116 |g extent:16 |a Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.coph.2020.07.006 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/article/pii/S1471489220300448 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210119 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 12146623X |a Herzig, Stephan |m 12146623X:Herzig, Stephan |d 50000 |e 50000PH12146623X |k 0/50000/ |p 3 |y j | ||
| 999 | |a KXP-PPN1744940991 |e 3839219213 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Claudia-Eveline Molocea, Foivos-Filippos Tsokanos and Stephan Herzig"]},"title":[{"title_sort":"Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies","title":"Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategies"}],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"29 August 2020"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 19.01.2021"],"relHost":[{"id":{"zdb":["2038524-9"],"eki":["325615276"],"issn":["1471-4973"]},"language":["eng"],"disp":"Exploiting common aspects of obesity and cancer cachexia for future therapeutic strategiesCurrent opinion in pharmacology","recId":"325615276","title":[{"title":"Current opinion in pharmacology","title_sort":"Current opinion in pharmacology"}],"part":{"pages":"101-116","year":"2020","volume":"53","text":"53(2020), Seite 101-116","extent":"16"},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2001-","dateIssuedKey":"2001","publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science"}],"pubHistory":["1.2001 -"],"note":["Gesehen am 16.01.20"],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"physDesc":[{"extent":"16 S."}],"id":{"doi":["10.1016/j.coph.2020.07.006"],"eki":["1744940991"]},"language":["eng"],"person":[{"family":"Molocea","role":"aut","given":"Claudia-Eveline","roleDisplay":"VerfasserIn","display":"Molocea, Claudia-Eveline"},{"family":"Tsokanos","role":"aut","roleDisplay":"VerfasserIn","given":"Foivos Filippos","display":"Tsokanos, Foivos Filippos"},{"role":"aut","family":"Herzig","display":"Herzig, Stephan","given":"Stephan","roleDisplay":"VerfasserIn"}],"recId":"1744940991"} | ||
| SRT | |a MOLOCEACLAEXPLOITING2920 | ||